⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DNTH News
Dianthus Therapeutics, Inc. Common Stock
Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
globenewswire.com
DNTH
Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
globenewswire.com
DNTH
Form 8-K
sec.gov
DNTH
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
DNTH
Dianthus Therapeutics to Participate in Two Investor Conferences
globenewswire.com
DNTH
Form 8-K
sec.gov
DNTH
LBL-047 Prioritized for Clinical Development in Sjögren's Disease, Systemic Lupus Erythematosus, and Dermatomyositis
globenewswire.com
DNTH
Form 8-K
sec.gov
DNTH
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 2026 Financial Results
globenewswire.com
DNTH
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
DNTH